Elevance Health, Inc. (ELV) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Elevance Health, Inc.'s filing signal turned negative.

Elevance Health is a leading health company operating across all 50 U.S. states, the District of Columbia, and Puerto Rico, serving approximately 45.2 million medical members as of December 31, 2025. The company offers a broad spectrum of network-based managed care plans, including risk-based and fee-based options for Individual, Employer Group, Medicare, and Medicaid markets. Through its go-to-market brands--Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon--Elevance Health provides integrated, whole health solutions, encompassing medical, pharmacy, and behavioral health services. Its business model generates revenue through premiums, administrative fees, and pharmacy and health service fees, supported by a national scale and local market focus. Elevance Health is an independent licensee of the Blue Cross and Blue Shield Association, leveraging this brand in its primary service areas.

Revenue is generated through risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through its Carelon businesses. The company also provides services to the federal government through its Federal Health Products & Services business.